Mr Benjamin E Rosenberg > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
Three Bryant Park, 1095 Avenue of the Americas
NY 10036-6797
United States
Mr Benjamin E Rosenberg

Work Department
Litigation
Career
Mr. Rosenberg joined Dechert as a partner in 2005 with a group of lawyers from Swidler Berlin Shereff Friedman. He has focused his practice on white collar criminal defense and securities litigation, with a specific emphasis on defending executives and corporations in connection with governmental investigations, and proceedings of federal grand juries and offices of the United States Attorney, the Securities and Exchange Commission, the Attorney General of New York, and the New York District Attorney. In 2013, he was a member of the Dechert litigation team recognized as part of the Financial Times’ 2013 Top U.S. Innovative Law Firms for their “standout” work acting as lead counsel for an ad hoc group of creditors in connection with the highly contested cross-border restructuring of approximately US$1.6 billion in defaulted senior notes issued by Mexico’s largest glass manufacturer, Vitro S.A.B. de C.V.
Education
Harvard University, A.B., 1981, magna cum laude; Harvard Law School, J.D., 1985, magna cum laude, Editor and Treasurer of the Harvard Law Review
Top Tier Firm Rankings
- Environment > Environment: transactional
- International trade and national security > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- International trade and national security > Customs, export controls and economic sanctions
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Healthcare > Life sciences
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending > Advice to direct lenders/private credit
- Dispute resolution > E-discovery
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- International trade and national security > Customs, export controls and economic sanctions
- Dispute resolution > Financial services litigation
- Finance > Fintech
- Dispute resolution > International arbitration
- Tax > International tax
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)